Dr. Sri Lakshmi Jasthy, MD

Dr. Jasthy practices at ECU Health Duplin Hospital in Kenansville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Jasthy's NPI, 1821230210, was assigned on March 31, 2009. Dr. Jasthy holds Pennsylvania license MD425326.

Dr. Jasthy's primary practice is ECU Health Duplin Hospital, at 401 N Main St, Kenansville, NC 28349 in Duplin County. The practice phone is (910) 296-0941.

Dr. Jasthy's primary practice is ECU Health Duplin Hospital in Kenansville, North Carolina, part of University Health Systems of Eastern Carolina. Dr. Jasthy is also affiliated with ECU Health Medical Center. The medical group on file is ECU Health. Dmand AI also links Dr. Jasthy to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jasthy practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jasthy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jasthy is licensed in Pennsylvania.

CMS data shows 354 Medicare services from Dr. Jasthy across 3 procedure codes in 2024, all of them office visits, for 144 Medicare patients. Medicare paid $24,854 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 144 Medicare patients who saw Dr. Jasthy in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jasthy's median patient age at 73, with 62% women.

In 2024, Dr. Jasthy wrote 610 Medicare Part D claims for 86 patients. 82% of them were for generic drugs. CMS names the drug for 459 of them, across 18 drugs with 11 or more claims each, at $249,759 in total drug cost. In 2023, CMS named 377 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Jasthy for performance year 2024, reported through an alternative payment model (APM). Dr. Jasthy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 37 general payments to Dr. Jasthy from 15 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $162.